Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study (CROSBI ID 271969)

Prilog u časopisu | Pismo uredniku | međunarodna recenzija

Živković, Maja ; Mihaljević Peles, Alma ; Muck-Šeler, Dorotea ; Šagud, Marina ; Ganoci, Lana ; Vlatković, Suzana ; Nikolac Perković, Matea ; Tudor, Lucija ; Božina, Nada ; Pivac, Nela The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study // Psychiatry research, 279 (2019), 389-390. doi: 10.1016/j.psychres.2019.04.028

Podaci o odgovornosti

Živković, Maja ; Mihaljević Peles, Alma ; Muck-Šeler, Dorotea ; Šagud, Marina ; Ganoci, Lana ; Vlatković, Suzana ; Nikolac Perković, Matea ; Tudor, Lucija ; Božina, Nada ; Pivac, Nela

engleski

The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study

The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients

schizophrenia ; olanzapine ; COMT ; polymorphism

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

279

2019.

389-390

objavljeno

0165-1781

1872-7123

10.1016/j.psychres.2019.04.028

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost